TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $412 | -16.9% | 19,849 | -1.7% | 0.02% | -15.0% |
| Q2 2023 | $496 | -39.9% | 20,194 | -0.6% | 0.02% | -41.2% |
| Q1 2023 | $825 | +70.5% | 20,309 | +88.5% | 0.03% | +61.9% |
| Q4 2022 | $484 | -99.6% | 10,773 | +334.6% | 0.02% | +320.0% |
| Q3 2022 | $119,000 | -28.3% | 2,479 | -11.7% | 0.01% | 0.0% |
| Q2 2022 | $166,000 | -49.1% | 2,806 | +0.1% | 0.01% | -37.5% |
| Q1 2022 | $326,000 | -3.8% | 2,802 | -27.0% | 0.01% | +14.3% |
| Q1 2021 | $339,000 | -7.6% | 3,840 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $367,000 | -27.3% | 3,840 | -13.7% | 0.01% | -33.3% |
| Q3 2020 | $505,000 | +14.8% | 4,450 | 0.0% | 0.01% | +9.1% |
| Q2 2020 | $440,000 | +50.7% | 4,450 | -1.9% | 0.01% | +37.5% |
| Q1 2020 | $292,000 | +6.6% | 4,534 | -1.5% | 0.01% | +33.3% |
| Q4 2019 | $274,000 | -1.8% | 4,603 | -2.8% | 0.01% | 0.0% |
| Q3 2019 | $279,000 | – | 4,736 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
| Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
| Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
| Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
| SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
| FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
| Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
| OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
| First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |